Ask AI
Barriers to Optimizing ART
Overcoming Fear of Virologic Failure: Barriers to Optimizing ART in People Living With HIV and Viral Suppression

Released: November 21, 2025

Activity

Progress
1
Course Completed

Fear of virologic failure is a major barrier to ensuring that people living with virally suppressed HIV are receiving the most optimal antiretroviral therapy (ART) regimen for them. Stream this Medical Minute to learn more about key guideline recommendations regarding ART switch and reassuring clinical data regarding efficacy, tolerability, and quality of life associated with switching a suppressive ART regimen. Topics covered include:

  • Efficacy of switching to 2-drug oral ART: real-world evidence
  • Real-world analyses of virologic failure with switch to long-acting cabotegravir plus rilpivirine
  • Patient selection to reduce risk of virologic failure with switch
  • Regimen-specific switch considerations